History of Lung Transplantation

  • Kapil Patel
  • David Weill


Since the first lung transplant in 1963, over 25,000 lung transplants have been performed worldwide in patients with a variety of advanced lung diseases. Currently, nearly 4000 lung transplants occur each year worldwide. The growth in the number of transplant operations performed is rooted in several evolutions that have occurred in the field since the procedure’s inception and its eventual acceptance as a viable alternative to patients with advanced lung disease (ALD). All of the advancements resulted from careful attention to the challenges faced by the early pioneers; outcomes have improved as surgical techniques, donor and recipient selection, and medical therapies have been refined. The median survival of patients transplanted between 2000 and 2006 was 5.5 years compared to 4 years for those transplanted between 1988 and 1994 [1]. Outcomes have only improved slightly in more recent years and remain far from ideal as chronic rejection has emerged as the leading obstacle to better long-term survival. Given that lung transplant recipients still lag other solid organ transplants in terms of survival, additional advances are still needed. However, these innovations will only result from a clear understanding of the history of the procedure and how it evolved to where we are today. This chapter will discuss the history and the major milestones in the field.


Lung transplant history Cytomegalovirus Ex vivo lung perfusion Lung allocation score Immunosuppression therapy 


  1. 1.
    Hertz MI, Aurora P, Christie JD, et al. Registry of the international society for heart and lung transplantation: a quarter century of thoracic transplantation. J Heart Lung Transplant. 2008;27:937–42.CrossRefGoogle Scholar
  2. 2.
    Hardy JD, Webb WR, Dalton ML Jr, Walker GR. Lung homotransplantation in man. JAMA. 1963;186:1065–74.CrossRefGoogle Scholar
  3. 3.
    Derom F, Barbier F, Ringoir S, et al. Ten-month survival after lung homotransplantations in man. J Thorac Cardiovasc Surg. 1971;61:835–46.PubMedGoogle Scholar
  4. 4.
    Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93:173–81.PubMedGoogle Scholar
  5. 5.
    Patterson GA, Cooper JD, Barr JH, Jones MT. Experimental and clinical double lung transplantation. J Thorac Cardiovasc Surg. 1988;95:70–4.PubMedGoogle Scholar
  6. 6.
    Starnes VA, Barr ML, Cohen RG. Lobar transplantation: indications, technique and outcome. J Thorac Cardiovasc Surg. 1994;108:403–10.PubMedGoogle Scholar
  7. 7.
    Cooley DA, Bloodwell RD, Hallman GL, et al. Organ transplantation for advanced cardiopulmonary disease. Ann Thorac Surg. 1969;8:30–42.CrossRefGoogle Scholar
  8. 8.
    Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306:557–64.CrossRefGoogle Scholar
  9. 9.
    Kshettry VR, Kroshus TJ, Hertz MI, et al. Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg. 1997;63:1576–83.CrossRefGoogle Scholar
  10. 10.
    Alvarez A, Algar J, Santos F, et al. Airway complications after lung transplantation: a review of 151 anastomoses. Eur J Cardiothorac Surg. 2001;19:381–7.CrossRefGoogle Scholar
  11. 11.
    Couraud L, Baudet E, Nashef SAM, et al. Lung transplantation with bronchial revascularization. Eur J Cardiothorac Surg. 1992;6:490–5.CrossRefGoogle Scholar
  12. 12.
    Pettersson GB, Karam K, Thuita L, et al. Comparative study of bronchial artery revascularization in lung transplantation. J Thorac Cardiovasc Surg. 2013;146:894–900.CrossRefGoogle Scholar
  13. 13.
    Siegelman SS, Hagstrom JW, Koerner SK, et al. Restoration of bronchial artery circulation after canine lung allotransplantation. J Thorac Cardiovasc Surg. 1977;73:792–5.PubMedGoogle Scholar
  14. 14.
    Pearson FG, Goldberg M, Stone RM, Colapinto RF. Bronchial arterial circulation restored after reimplantation of canine lung. Can J Surg. 1970;13:243–50.PubMedGoogle Scholar
  15. 15.
    Wildevuur CR, Benfield JR. A review of 23 human lung transplantations by 20 surgeons. Ann Thorac Surg. 1970;9:489–515.CrossRefGoogle Scholar
  16. 16.
    Calne RY, White DJ, Thiru S, et al. Cyclosporine a in patients receiving renal allografts from cadaver donors. Lancet. 1978;2:1323–7.CrossRefGoogle Scholar
  17. 17.
    Cooper JD. Herbert Sloan lecture. Lung transplantation. Ann Thorac Surg. 1989;47:28–44.CrossRefGoogle Scholar
  18. 18.
    Lima O, Cooper JD, Peters WJ, et al. Effects of methylprednisone and azathioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg. 1981;82:211–5.PubMedGoogle Scholar
  19. 19.
    Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplants in humans. J Thorac Cardiovasc Surg. 1987;93:173–81.PubMedGoogle Scholar
  20. 20.
    Patterson GA, Cooper JD, Goldman B, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg. 1988;45:626–33.CrossRefGoogle Scholar
  21. 21.
    Patterson GA, Todd TR, Cooper JD, et al. Airway complications after double lung transplantation. Toronto lung transplant group. J Thorac Cardiovasc Surg. 1990;99:14–20.PubMedGoogle Scholar
  22. 22.
    Garfein ES, Ginsberg ME, Gorenstein L, et al. Superiority of end-to-end versus telescoped bronchial anastomosis in single lung transplantation for pulmonary emphysema. J Thorac Cardiovasc Surg. 2001;121:149–54.CrossRefGoogle Scholar
  23. 23.
    Vieth FJ, Kambolg SL, Mollenkopf FP, Montefusco CM. Lung transplantation 1983. Transplantation. 1983;35:271–8.CrossRefGoogle Scholar
  24. 24.
    Kaiser LR, Pasque MK, Trulock EP, et al. Bilateral sequential lung transplantation: the procedure of choice for double-lung replacement. Ann Thorac Surg. 1991;52:438–46.CrossRefGoogle Scholar
  25. 25.
    Fukuse T, Albes JM, Brandes H, et al. Comparison of low potassium Euro-Collins solution and standard Euro-Collins solution in an extracorporeal rat heart-lung model. Eur J Cardiothorac Surg. 1996;10:621–7.CrossRefGoogle Scholar
  26. 26.
    Yamazaki F, Yokomise H, Keshavjee SH, et al. The superiority of an extracellular fluid solution over Euro-Collins’ solution for pulmonary preservation. Transplantation. 1990;49:690–4.CrossRefGoogle Scholar
  27. 27.
    Okada Y, Kondo T. Impact of lung preservation solutions, Euro-Collins vs low-potassium dextran, on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg. 2006;12:10–4.PubMedGoogle Scholar
  28. 28.
    Roman A, Manito N, Campistol JM, et al. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Transplant Rev (Orlando). 2014;28:84–91.CrossRefGoogle Scholar
  29. 29.
    McDevitt LM. Etiology and impact of cytomegalovirus disease on solid organ transplant recipients. Am J Health Syst Pharm. 2006;63(19 Supple 5):S3–9.CrossRefGoogle Scholar
  30. 30.
    Meylan PR, Manuel O. Late onset cytomegalovirus disease in patients with solid organ transplant. Curr Opin Infect Dis. 2007;20:412–8.CrossRefGoogle Scholar
  31. 31.
    Sagedal S, Nordal KP, Hartman A, et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation. 2000;70:1166–74.CrossRefGoogle Scholar
  32. 32.
    Manuel O, Kralidis G, Mueller NJ, et al. Impact of antiviral preventive strategies on the incidence and outcome of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2013;13:2402–10.CrossRefGoogle Scholar
  33. 33.
    Freeman RB. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant. 2009;9:2453–8.CrossRefGoogle Scholar
  34. 34.
    Kroshus TJ, Kshettry VR, Savik K, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg. 1997;114:195–202.CrossRefGoogle Scholar
  35. 35.
    Synder LD, Finlen-Copeland AF, Turbyfill WJ, et al. Cytomegalovirus pneumonitis is a risk factor for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med. 2010;181:1391–6.CrossRefGoogle Scholar
  36. 36.
    Rubin RH, Kemmerly SA, Conti D, et al. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis. 2000;2:112–7.CrossRefGoogle Scholar
  37. 37.
    Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994;150:146–52.CrossRefGoogle Scholar
  38. 38.
    Speich R, Thurnheer R, Gaspert A, et al. Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation. Transplantation. 1999;67:315–20.CrossRefGoogle Scholar
  39. 39.
    Pescovitz MD, Rabkin J, Merion RM, et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother. 2000;44:2811–5.CrossRefGoogle Scholar
  40. 40.
    Hertz MI, Jordan C, Savik SK, et al. Randomized trial of daily versus three-times weekly prophylactic ganciclovir after lung and heart-lung transplantation. J Heart Lung Transplant. 1998;17:913–20.PubMedGoogle Scholar
  41. 41.
    Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of CMV disease in solid organ transplant recipients. Am J Transplant. 2004;4:611–20.CrossRefGoogle Scholar
  42. 42.
    Zamora MR, Nicolls MR, Hodges TN, et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant. 2004;4:1635–42.CrossRefGoogle Scholar
  43. 43.
    Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation. Ann Intern Med. 2010;152:761–9.CrossRefGoogle Scholar
  44. 44.
    Schoeppler KE, Lyu DM, Grazia TJ, et al. Late-onset cytomegalovirus (CMV) in lung transplant recipients: can CMV serostatus guide the duration of prophylaxis? Am J Transplant. 2013;13:376–82.CrossRefGoogle Scholar
  45. 45.
    Department of Health and Human Services. Organ Procurement and Transplantation Network; final rule. In: Federal Register 42 CFR, Part 121, October 20, 1999:56649–56661.Google Scholar
  46. 46.
    Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(Part 2):1212–27.CrossRefGoogle Scholar
  47. 47.
    Fisher AJ, Donnelly SC, Pritchard G, et al. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax. 2004;59:434–7.CrossRefGoogle Scholar
  48. 48.
    Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19:1199–204.CrossRefGoogle Scholar
  49. 49.
    Kron IL, Tribble CG, Kern JA, et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg. 1993;217:518–22.CrossRefGoogle Scholar
  50. 50.
    Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995;109:1075–9.CrossRefGoogle Scholar
  51. 51.
    Mason DP, Thuita L, Alster JM, et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg. 2008;136:1061–6.CrossRefGoogle Scholar
  52. 52.
    Snell GI, Levvey BJ, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant. 2008;8:1282–9.CrossRefGoogle Scholar
  53. 53.
    De VS, Van RD, Vanaudenaerde B, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant. 2009;28:380–7.CrossRefGoogle Scholar
  54. 54.
    Mason DP, Murthy SC, Gonzalez-Stawinski GV, et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant. 2008;27:561–3.CrossRefGoogle Scholar
  55. 55.
    De Oliveira NC, Osaki S, Maloney JD, et al. Lung transplantation with donation after cardiac death donors: long-term follow up in a single center. J Thorac Cardiovasc Surg. 2010;139:1306–15.CrossRefGoogle Scholar
  56. 56.
    Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357:825–9.CrossRefGoogle Scholar
  57. 57.
    Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S. Ex-vivo lung perfusion. Transpl Int. 2015;28:643–56.CrossRefGoogle Scholar
  58. 58.
    Machuca TN, Cypel M. Ex vivo lung perfusion. J Thorac Dis. 2014;6:1054–62.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Center for Advanced Lung Disease, Division of Pulmonary and Critical Care Medicine, Morsani College of MedicineUniversity of South FloridaTampaUSA
  2. 2.Weill Consulting GroupNew OrleansUSA

Personalised recommendations